Sheldon Berger
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
-
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Diabetes Management and Research 3
- Thyroid Disorders and Treatments 2
- Surgery 7
- Pancreatic function and diabetes 6
- Co-authors
- Robert Metz (3 shared papers)Mary E. Mako (2 shared papers)Vivian Fonseca (1 shared paper)Stephen P. Thomson (1 shared paper)David S.H. Bell (1 shared paper)J. P. Raufman (1 shared paper)Vincent Woo (1 shared paper)P. Raskin (1 shared paper)
- Journals
- Diabetes (4 papers)New England Journal of Medicine (2 papers)Annals of the New York Academy of Sciences (2 papers)Experimental Biology and Medicine (1 paper)American Journal of Physiology-Legacy Content (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Sheldon Berger
24 papers receiving 359 citations
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 180
- Pharmacology 62
- Surgery 108
- Pathology and Forensic Medicine 43
- Physiology 61
Countries citing papers authored by Sheldon Berger
This map shows the geographic impact of Sheldon Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Berger more than expected).
Fields of papers citing papers by Sheldon Berger
This network shows the impact of papers produced by Sheldon Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Berger. The network helps show where Sheldon Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheldon Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1969 | 75 | |
| 2 | 1966 | 63 | |
| 3 | 2004 | 53 | |
| 4 | 2000 | 47 | |
| 5 | 2000 | 41 | |
| 6 | 1952 | 28 | |
| 7 | 1985 | 16 | |
| 8 | 1968 | 14 | |
| 9 | 1966 | 10 | |
| 10 | 1962 | 9 | |
| 11 | 1952 | 8 | |
| 12 | 1979 | 7 | |
| 13 | 1970 | 6 | |
| 14 | General pharmacology of S 15261, a new concept for treatment of diabetes. | 1998 | 6 |
| 15 | [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus]. | 2000 | 6 |
| 16 | 1968 | 5 | |
| 17 | 1967 | 4 | |
| 18 | 1953 | 4 | |
| 19 | Preservation of insulin and liver glycogen stores during very long fasts. | 1968 | 4 |
| 20 | 1995 | 3 |
About Sheldon Berger
Sheldon Berger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Epidemiology and Cell Biology, having authored 24 papers that have together received 417 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (6 papers), Diabetes Management and Research (3 papers), Muscle metabolism and nutrition (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Diabetes and associated disorders (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Pharmacology and Obesity Treatment (2 papers) and Thyroid Disorders and Treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (180 citations), Pharmacology (62 citations), Surgery (108 citations), Pathology and Forensic Medicine (43 citations) and Physiology (61 citations). Sheldon Berger has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert Metz, Mary E. Mako, Vivian Fonseca, Stephen P. Thomson, David S.H. Bell, J. P. Raufman, Vincent Woo, P. Raskin, Robert E. Ratner and Lois Jovanovič. Their work appears in journals such as Diabetes, New England Journal of Medicine, Annals of the New York Academy of Sciences, Experimental Biology and Medicine and American Journal of Physiology-Legacy Content.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.